|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1001 to 1100 out of 1188 for Gem

0.019s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Allele
Name: rad and gem related GTP binding protein 2; targeted mutation 1c, Helmholtz Zentrum Muenchen GmbH
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Strain
Attribute String: coisogenic, targeted mutation
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Genotype
Symbol: Gemin2/Gemin2
Background: involves: 129P2/OlaHsd * C57BL/6
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Rem1/Rem1
Background: involves: 129S6/SvEvTac * Black Swiss
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Gemin4/Gemin4
Background: involves: 129S5/SvEvBrd * C57BL/6J
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Rem2/Rem2
Background: 129S2.B6N-Rem2
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Rem2/Rem2
Background: C57BL/6-Rem2
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Rem2/Rem2
Background: involves: 129S4/SvJaeSor * C57BL/6N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Gemin6/Gemin6
Background: C57BL/6N-Gemin6/Mmmh
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Gemin6/Gemin6
Background: C57BL/6N-Gemin6/BayMmucd
Zygosity: hm
Has Mutant Allele: true
Publication
First Author: Carissimi C
Year: 2006
Journal: J Biol Chem
Title: Gemin8 is a novel component of the survival motor neuron complex and functions in small nuclear ribonucleoprotein assembly.
Volume: 281
Issue: 12
Pages: 8126-34
Publication  
First Author: Salman B
Year: 2024
Journal: Int J Mol Sci
Title: Understanding the Role of the SMN Complex Component GEMIN5 and Its Functional Relationship with Demethylase KDM6B in the Flunarizine-Mediated Neuroprotection of Motor Neuron Disease Spinal Muscular Atrophy.
Volume: 25
Issue: 18
Publication    
First Author: Strausberg R
Year: 2001
Journal: GenBank Submission
Title: Mus musculus, clone IMAGE: 3483507, mRNA, partial cds
Pages: BC005604
Publication
First Author: Beqollari D
Year: 2015
Journal: J Gen Physiol
Title: Rem uncouples excitation-contraction coupling in adult skeletal muscle fibers.
Volume: 146
Issue: 1
Pages: 97-108
Genotype
Symbol: Gemin5/Gemin5<+>
Background: C57BL/6N-Gemin5/H
Zygosity: ht
Has Mutant Allele: true
Genotype
Symbol: Gemin4/Gemin4<+>
Background: C57BL/6N-Gemin4/Ics
Zygosity: ht
Has Mutant Allele: true
Allele
Name: transgene insertion 1, Jeffery Molkentin
Allele Type: Transgenic
Attribute String: Inducible, Inserted expressed sequence
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Strain
Attribute String: mutant strain, targeted mutation
Strain
Attribute String: mutant strain, coisogenic, targeted mutation
Genotype
Symbol: Rem2/Rem2 Pvalb/Pvalb<+>
Background: involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Finlin BS
Year: 1999
Journal: Arch Biochem Biophys
Title: Phosphorylation-dependent association of the Ras-related GTP-binding protein Rem with 14-3-3 proteins.
Volume: 368
Issue: 2
Pages: 401-12
Strain
Attribute String: transgenic, mutant strain, coisogenic
HT Experiment  
Experiment Type: RNA-Seq
Study Type: Baseline
Source: GEO
Publication
First Author: Thevenet L
Year: 2005
Journal: J Biol Chem
Title: NHERF2/SIP-1 interacts with mouse SRY via a different mechanism than human SRY.
Volume: 280
Issue: 46
Pages: 38625-30
Publication
First Author: Tucker KE
Year: 2001
Journal: J Cell Biol
Title: Residual Cajal bodies in coilin knockout mice fail to recruit Sm snRNPs and SMN, the spinal muscular atrophy gene product.
Volume: 154
Issue: 2
Pages: 293-307
Publication
First Author: Fallini C
Year: 2014
Journal: Dev Neurobiol
Title: Dynamics of survival of motor neuron (SMN) protein interaction with the mRNA-binding protein IMP1 facilitates its trafficking into motor neuron axons.
Volume: 74
Issue: 3
Pages: 319-332
Publication
First Author: Heralde FM 3rd
Year: 2008
Journal: Toxicon
Title: A rapidly diverging superfamily of peptide toxins in venomous Gemmula species.
Volume: 51
Issue: 5
Pages: 890-7
Protein Domain
Type: Family
Description: Proteins in this family are disulphide-rich peptides expressed in Gemmula venom ducts in the gem turrids (venomous snails in the family Turridae) [].There are more than 10,000 species of predatory marine snail that use venom as their primary weapon for prey capture. Based on shell morphology, they are traditionally divided into 3 groups: cone snails, augers and turrids. Most molluscan taxonomies assign cone snails to a single large genus, Conus, while augers are assigned to several different genera; by contrast, the turrids represent a group that is much more diverse, and is now thought to comprise the vast majority of conoidean biodiversity [].The venom peptides from several species in the genus Gemmula, the gem turrids, have been characterised. Their translated open reading frames show characteristics typical of the venom peptides from Conus: an N-terminal signal sequence; a C-terminal cysteine-rich mature peptide; and an intervening pro-region. Two of these sequences, Gsp9.1 and Gsp9.2, have highly similar signal and propeptide regions, while their predicted mature peptides are more divergent (although the cysteine residues are completely conserved) []. This pattern of highly conserved and more variable regions is characteristic of gene superfamilies encoding the toxin peptides found in Conus venoms.
Genotype
Symbol: Gemin2/Gemin2<+> Smn1/Smn1<+>
Background: involves: 129P2/OlaHsd * C57BL/6 * MF1
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Rem2/Rem2 Emx1/Emx1<+>
Background: involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Rem2/Rem2 Gt(ROSA)26Sor/Gt(ROSA)26Sor<+>
Background: involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Rem2/Rem2 Vip/Vip<+>
Background: involves: 129S4/SvJaeSor * C57BL/6N
Zygosity: cn
Has Mutant Allele: true
HT Experiment  
Experiment Type: RNA-Seq
Study Type: Baseline
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: Baseline
Source: ArrayExpress
Publication
First Author: Takada Y
Year: 2023
Journal: Sci Adv
Title: Mature mRNA processing that deletes 3' end sequences directs translational activation and embryonic development.
Volume: 9
Issue: 47
Pages: eadg6532
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: Baseline
Source: GEO
Publication
First Author: Jerez-Timaure NC
Year: 2005
Journal: Physiol Genomics
Title: Fine mapping of a QTL region with large effects on growth and fatness on mouse chromosome 2.
Volume: 21
Issue: 3
Pages: 411-22
Publication
First Author: Küry S
Year: 2017
Journal: Am J Hum Genet
Title: De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability.
Volume: 101
Issue: 5
Pages: 768-788
Publication
First Author: Vincentz JW
Year: 2019
Journal: Circ Res
Title: Variation in a Left Ventricle-Specific Hand1 Enhancer Impairs GATA Transcription Factor Binding and Disrupts Conduction System Development and Function.
Volume: 125
Issue: 6
Pages: 575-589
Publication
First Author: Gabanella F
Year: 2005
Journal: Hum Mol Genet
Title: The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation.
Volume: 14
Issue: 23
Pages: 3629-42
Publication
First Author: Britanova O
Year: 2008
Journal: Neuron
Title: Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex.
Volume: 57
Issue: 3
Pages: 378-92
Publication
First Author: Weng Q
Year: 2012
Journal: Neuron
Title: Dual-mode modulation of Smad signaling by Smad-interacting protein Sip1 is required for myelination in the central nervous system.
Volume: 73
Issue: 4
Pages: 713-28
Publication
First Author: Delprato A
Year: 2015
Journal: Genes Brain Behav
Title: Systems genetic analysis of hippocampal neuroanatomy and spatial learning in mice.
Volume: 14
Issue: 8
Pages: 591-606
Publication
First Author: Shaw L
Year: 2010
Journal: In Vitro Cell Dev Biol Anim
Title: Gene expression profiling of the developing mouse kidney and embryo.
Volume: 46
Issue: 2
Pages: 155-65
HT Experiment  
Experiment Type: RNA-Seq
Study Type: Baseline
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: Baseline
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
Publication
First Author: Shakya R
Year: 2011
Journal: Science
Title: BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity.
Volume: 334
Issue: 6055
Pages: 525-8
Publication
First Author: Jeong JH
Year: 2008
Journal: PLoS One
Title: BRAF activation initiates but does not maintain invasive prostate adenocarcinoma.
Volume: 3
Issue: 12
Pages: e3949
Publication
First Author: Mitrofanova A
Year: 2015
Journal: Cell Rep
Title: Predicting Drug Response in Human Prostate Cancer from Preclinical Analysis of In Vivo Mouse Models.
Volume: 12
Issue: 12
Pages: 2060-71
Publication
First Author: Liu Y
Year: 2021
Journal: Nat Commun
Title: Convergence of oncogenic cooperation at single-cell and single-gene levels drives leukemic transformation.
Volume: 12
Issue: 1
Pages: 6323
Publication
First Author: Shields MA
Year: 2022
Journal: Cell Rep
Title: Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin.
Volume: 38
Issue: 9
Pages: 110441
Publication
First Author: Cardiff RD
Year: 2000
Journal: J Mammary Gland Biol Neoplasia
Title: Genetically engineered mouse models of mammary intraepithelial neoplasia.
Volume: 5
Issue: 4
Pages: 421-37
Publication
First Author: Ahmad I
Year: 2012
Journal: Dis Model Mech
Title: Exploring molecular genetics of bladder cancer: lessons learned from mouse models.
Volume: 5
Issue: 3
Pages: 323-32
Publication
First Author: Ju HL
Year: 2016
Journal: Int J Cancer
Title: Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy.
Volume: 138
Issue: 7
Pages: 1601-8
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
Publication
First Author: Lee KH
Year: 2000
Journal: J Immunol
Title: Stimulatory function of gp49A, a murine Ig-like receptor, in rat basophilic leukemia cells.
Volume: 165
Issue: 9
Pages: 4970-7
Publication
First Author: Szabova L
Year: 2014
Journal: PLoS One
Title: Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancer.
Volume: 9
Issue: 4
Pages: e95649
Publication
First Author: Weiss WA
Year: 2002
Journal: Oncogene
Title: Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum.
Volume: 21
Issue: 49
Pages: 7453-63
Publication
First Author: Brown JA
Year: 2010
Journal: Hum Mol Genet
Title: Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.
Volume: 19
Issue: 22
Pages: 4515-28
Publication
First Author: Warrington NM
Year: 2010
Journal: Cancer Res
Title: Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.
Volume: 70
Issue: 14
Pages: 5717-27
Publication
First Author: Zhu M
Year: 2011
Journal: Genome Biol
Title: Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
Volume: 12
Issue: 8
Pages: R77
Publication
First Author: Klein RD
Year: 2005
Journal: Mutat Res
Title: The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
Volume: 576
Issue: 1-2
Pages: 111-9
Publication
First Author: Wu R
Year: 2011
Journal: Clin Cancer Res
Title: Preclinical testing of PI3K/AKT/mTOR signaling inhibitors in a mouse model of ovarian endometrioid adenocarcinoma.
Volume: 17
Issue: 23
Pages: 7359-72
Publication
First Author: Shai A
Year: 2015
Journal: Cancer Res
Title: TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis.
Volume: 75
Issue: 15
Pages: 3167-80
Publication
First Author: Xie Y
Year: 2017
Journal: Sci Rep
Title: Dysregulation of YAP by ARF Stimulated with Tea-derived Carbon Nanodots.
Volume: 7
Issue: 1
Pages: 16577
Publication
First Author: Cardiff RD
Year: 2000
Journal: Oncogene
Title: The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.
Volume: 19
Issue: 8
Pages: 968-88
Publication
First Author: Guo X
Year: 2019
Journal: PLoS One
Title: Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse.
Volume: 14
Issue: 2
Pages: e0212930
Publication
First Author: De Velasco MA
Year: 2016
Journal: Oncotarget
Title: Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer.
Volume: 7
Issue: 13
Pages: 15959-76
Publication
First Author: Green S
Year: 2015
Journal: Cancer Res
Title: PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Volume: 75
Issue: 24
Pages: 5378-91
Publication
First Author: Zou M
Year: 2017
Journal: Cancer Discov
Title: Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.
Volume: 7
Issue: 7
Pages: 736-749
Publication
First Author: Hegedus B
Year: 2008
Journal: Cancer Res
Title: Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.
Volume: 68
Issue: 5
Pages: 1520-8
Publication
First Author: Trejo CL
Year: 2012
Journal: Cancer Res
Title: MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E.
Volume: 72
Issue: 12
Pages: 3048-59
Publication
First Author: Inokuchi S
Year: 1998
Journal: Virchows Arch
Title: Angiotensin II maintains the structure and function of glomerular mesangium via type 1a receptor. What we have learned from null mutant mice minus the angiotensin II type 1a receptor gene.
Volume: 433
Issue: 4
Pages: 349-57
Publication  
First Author: Wu C
Year: 2023
Journal: JCI Insight
Title: Reactive myelopoiesis and FX-expressing macrophages triggered by chemotherapy promote cancer lung metastasis.
Volume: 8
Issue: 9
Publication
First Author: Song Y
Year: 2013
Journal: PLoS One
Title: Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.
Volume: 8
Issue: 12
Pages: e80459
Publication
First Author: Prada CE
Year: 2013
Journal: Acta Neuropathol
Title: Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.
Volume: 125
Issue: 1
Pages: 159-68
Publication
First Author: Wu J
Year: 2012
Journal: Pediatr Blood Cancer
Title: Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
Volume: 58
Issue: 2
Pages: 173-80
Publication
First Author: Nix M
Year: 2000
Journal: Cell Death Differ
Title: Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation.
Volume: 7
Issue: 5
Pages: 413-24
Publication
First Author: Wang L
Year: 2022
Journal: Cancer Res Commun
Title: World Trade Center dust exposure promotes cancer in PTEN-deficient mouse prostates.
Volume: 2
Issue: 6
Pages: 518-532
Publication
First Author: Grüner BM
Year: 2012
Journal: PLoS One
Title: MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.
Volume: 7
Issue: 6
Pages: e39424
Publication
First Author: Layeghi-Ghalehsoukhteh S
Year: 2020
Journal: Sci Rep
Title: Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics.
Volume: 10
Issue: 1
Pages: 20662
Publication
First Author: Hocker JR
Year: 2013
Journal: Int J Cancer
Title: Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation.
Volume: 133
Issue: 11
Pages: 2662-71
Publication
First Author: Mohammed A
Year: 2015
Journal: Oncotarget
Title: Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression.
Volume: 6
Issue: 17
Pages: 15524-39
Publication
First Author: Courtin A
Year: 2013
Journal: PLoS One
Title: Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer.
Volume: 8
Issue: 6
Pages: e67330
Publication    
First Author: Wang Z
Year: 2019
Journal: JCI Insight
Title: Gonadotrope androgen receptor mediates pituitary responsiveness to hormones and androgen-induced subfertility.
Volume: 5
Publication
First Author: Deuker MM
Year: 2015
Journal: Cancer Discov
Title: PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanoma.
Volume: 5
Issue: 2
Pages: 143-53
Publication
First Author: Kavanaugh C
Year: 2003
Journal: J Nutr
Title: The use of genetically altered mice for breast cancer prevention studies.
Volume: 133
Issue: 7 Suppl
Pages: 2404S-2409S